The Latest Breaking News from Tylenol

Kleenex maker’s deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny

When corporate crises hit, the public looks to the CEO. From product recalls to workplace discrimination, to customer mistreatment scandals, CEOs are often thrust into the spotlight and forced to apologize.

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the White House. Late last month, President Donald Trump stated on Truth Social that pregnant women shouldn't use Tylenol unless absolutely necessary. With…

Promotion of unproven claims from President Trump and RFK Jr. linking acetaminophen (Tylenol) to autism have significantly impacted Kenvue’s business.

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.

Trump was eager to single out drug manufacturer despite no new evidence to support administration’s unproven claims

Kenvue stock is trailing the broader markets by a wide margin in 2025 due to regulatory concerns over its flagship Tylenol product.

Late-night hosts celebrate the return of Kimmel and recap Trump’s ‘insane’ press conference baselessly blaming Tylenol for autism

After Trump claimed Tylenol during pregnancy causes autism, people online responded with criticism, memes, expert refutations. See the reactions.